A novel soluble guanylate cyclase activator, avenciguat, in combination with empagliflozin, protects against renal and hepatic injury in diabetic <i>db/db</i> mice. [PDF]
Sharma N +8 more
europepmc +1 more source
Pharmacological Stimulation of Soluble Guanylate Cyclase Counteracts the Profibrotic Activation of Human Conjunctival Fibroblasts. [PDF]
Fioretto BS +6 more
europepmc +1 more source
Pericyte signaling via soluble guanylate cyclase shapes the vascular niche and microenvironment of tumors. [PDF]
Zhu J +13 more
europepmc +1 more source
Soluble guanylate cyclase stimulators and activators: new horizons in the treatment of priapism associated with sickle cell disease. [PDF]
Pereira DA +3 more
europepmc +1 more source
Soluble guanylate cyclase stimulators for heart failure: a network meta-analysis and subgroup analyses of reduced and preserved ejection fraction. [PDF]
Abuelazm MT +8 more
europepmc +1 more source
Safety, tolerability, pharmacokinetics, and pharmacodynamics of a soluble guanylate cyclase stimulator, HEC95468, in healthy volunteers: a randomized, double-blinded, placebo-controlled phase 1 trial. [PDF]
Gui YZ +11 more
europepmc +1 more source
Expression and activity of soluble guanylate cyclase in injury and repair of anti-thy1 glomerulonephritis [PDF]
Expression and activity of soluble guanylate cyclase in injury and repair of anti-thy1 glomerulonephritis.BackgroundActivation of soluble guanylate cyclase and generation of cyclic 3′,5′-guanosine monophosphate (cGMP) is the main signal transducing event
Harm Peters +2 more
exaly +2 more sources
Stimulation of soluble guanylate cyclase slows progression in anti-thy1-induced chronic glomerulosclerosis [PDF]
Stimulation of soluble guanylate cyclase slows progression in anti-thy1-induced chronic glomerulosclerosis.BackgroundA critical role of soluble guanylate cyclase and nitric oxide-dependent cyclic 3′,5′-guanosine monophosphate (cGMP) production for ...
Hiroshi Kawachi +2 more
exaly +2 more sources
Related searches:
Soluble Guanylate Cyclase as an Emerging Therapeutic Target in Cardiopulmonary Disease
Circulation, 2011Pal Pacher +2 more
exaly

